...
vir-img

Vir Biotechnology Inc, Common Stock

VIR

NSQ

$7.156

-$0.19

(-2.59%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.04B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.04M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.56 L
$13.09 H
$7.156

About Vir Biotechnology Inc, Common Stock

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVIRSectorS&P500
1-Week Return-6.01%-2.06%-0.55%
1-Month Return4.55%-1.92%2.72%
3-Month Return-5.77%-10.4%7.66%
6-Month Return-17.88%-4.6%10.15%
1-Year Return-24.38%4.06%27.53%
3-Year Return-85.63%1.94%32.31%
5-Year Return-40.63%36.48%89.2%
10-Year Return-47.57%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue711.00K76.37M1.09B1.58B86.18M[{"date":"2019-12-31","value":0.04,"profit":true},{"date":"2020-12-31","value":4.83,"profit":true},{"date":"2021-12-31","value":68.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.45,"profit":true}]
Cost of Revenue143.07M301.58M65.86M146.32M2.77M[{"date":"2019-12-31","value":47.44,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.84,"profit":true},{"date":"2022-12-31","value":48.52,"profit":true},{"date":"2023-12-31","value":0.92,"profit":true}]
Gross Profit711.00K76.37M1.02B1.43B83.42M[{"date":"2019-12-31","value":0.05,"profit":true},{"date":"2020-12-31","value":5.32,"profit":true},{"date":"2021-12-31","value":71.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.82,"profit":true}]
Gross Margin100.00%100.00%93.94%90.74%96.79%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.94,"profit":true},{"date":"2022-12-31","value":90.74,"profit":true},{"date":"2023-12-31","value":96.79,"profit":true}]
Operating Expenses178.69M373.35M600.45M601.09M767.72M[{"date":"2019-12-31","value":23.28,"profit":true},{"date":"2020-12-31","value":48.63,"profit":true},{"date":"2021-12-31","value":78.21,"profit":true},{"date":"2022-12-31","value":78.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(177.98M)(296.98M)276.89M833.07M(684.30M)[{"date":"2019-12-31","value":-21.36,"profit":false},{"date":"2020-12-31","value":-35.65,"profit":false},{"date":"2021-12-31","value":33.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-82.14,"profit":false}]
Total Non-Operating Income/Expense11.96M299.52M129.49M(50.70M)138.54M[{"date":"2019-12-31","value":3.99,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":43.23,"profit":true},{"date":"2022-12-31","value":-16.93,"profit":false},{"date":"2023-12-31","value":46.25,"profit":true}]
Pre-Tax Income(174.53M)(298.61M)549.80M754.28M(628.19M)[{"date":"2019-12-31","value":-23.14,"profit":false},{"date":"2020-12-31","value":-39.59,"profit":false},{"date":"2021-12-31","value":72.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-83.28,"profit":false}]
Income Taxes154.00K(54.00K)21.22M238.44M(13.08M)[{"date":"2019-12-31","value":0.06,"profit":true},{"date":"2020-12-31","value":-0.02,"profit":false},{"date":"2021-12-31","value":8.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.48,"profit":false}]
Income After Taxes(174.68M)(298.56M)528.58M515.84M(615.12M)[{"date":"2019-12-31","value":-33.05,"profit":false},{"date":"2020-12-31","value":-56.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-116.37,"profit":false}]
Income From Continuous Operations(174.68M)(298.67M)528.58M515.84M(600.75M)[{"date":"2019-12-31","value":-33.05,"profit":false},{"date":"2020-12-31","value":-56.5,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-113.65,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(174.68M)(298.67M)528.58M515.84M(615.06M)[{"date":"2019-12-31","value":-33.05,"profit":false},{"date":"2020-12-31","value":-56.5,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-116.36,"profit":false}]
EPS (Diluted)(6.00)(2.48)3.883.81(4.59)[{"date":"2019-12-31","value":-154.51,"profit":false},{"date":"2020-12-31","value":-63.92,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.2,"profit":true},{"date":"2023-12-31","value":-118.3,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VIR
Cash Ratio 8.52
Current Ratio 8.94
Quick Ratio 8.98

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VIR
ROA (LTM) -19.41%
ROE (LTM) -36.58%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VIR
Debt Ratio Lower is generally better. Negative is bad. 0.17
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.83

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VIR
Trailing PE NM
Forward PE 4.36
P/S (TTM) 13.24
P/B 0.84
Price/FCF NM
EV/R 3.86
EV/Ebitda 0.90

FAQs

What is Vir Biotechnology Inc share price today?

Vir Biotechnology Inc (VIR) share price today is $7.156

Can Indians buy Vir Biotechnology Inc shares?

Yes, Indians can buy shares of Vir Biotechnology Inc (VIR) on Vested. To buy Vir Biotechnology Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VIR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vir Biotechnology Inc be purchased?

Yes, you can purchase fractional shares of Vir Biotechnology Inc (VIR) via the Vested app. You can start investing in Vir Biotechnology Inc (VIR) with a minimum investment of $1.

How to invest in Vir Biotechnology Inc shares from India?

You can invest in shares of Vir Biotechnology Inc (VIR) via Vested in three simple steps:

  • Click on Sign Up or Invest in VIR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vir Biotechnology Inc shares
What is Vir Biotechnology Inc 52-week high and low stock price?

The 52-week high price of Vir Biotechnology Inc (VIR) is $13.09. The 52-week low price of Vir Biotechnology Inc (VIR) is $6.56.

What is Vir Biotechnology Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vir Biotechnology Inc (VIR) is

What is Vir Biotechnology Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vir Biotechnology Inc (VIR) is 0.84

What is Vir Biotechnology Inc dividend yield?

The dividend yield of Vir Biotechnology Inc (VIR) is 0.00%

What is the Market Cap of Vir Biotechnology Inc?

The market capitalization of Vir Biotechnology Inc (VIR) is $1.04B

What is Vir Biotechnology Inc’s stock symbol?

The stock symbol (or ticker) of Vir Biotechnology Inc is VIR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top